At best it was simply advertising that backfired on them due to a misunderstanding of what they are working to achieve. This is clearly out of the way now and can not be even considered against their current approach.
And the second article i note specifically that this is nothing more then a rant from a professional (GP) that at that time would of been bypassed and disrupted by this product. I seen this resistance with RAP as well and in our case NTI has already overcome this issue since that report. There is strong support from the professional clinical side and they want to now collaborate with AAT research (NTI) as per my meeting with management.
You do not attract such attention from the carrick institute if you were not of high caliber.
You do not get asked to go to the worlds largest neuroscience convention and be the main speaker if you are not high caliber.
SIMPLE
DO SOME RESEARCH.
NTI Price at posting:
44.5¢ Sentiment: Buy Disclosure: Held
